Mar 06, 2017 13:00 pm UTC| Business
OAKBROOK TERRACE, Ill., March 06, 2017 -- VASCO Data Security International, Inc. (NASDAQ:VDSI), a global leader in digital solutions including identity, security and business productivity, today announced that Info...
Lipocine to Present at 29th Annual ROTH Conference
Mar 06, 2017 13:00 pm UTC| Business
SALT LAKE CITY, March 06, 2017 -- Lipocine Inc. (NASDAQ:LPCN), a specialty pharmaceutical company, today announced that Mahesh Patel, President and CEO, and Morgan Brown, Executive Vice President and CFO, will present a...
Xcel Brands to Report Fourth Quarter and Full Year 2016 Financial Results on March 22, 2017
Mar 06, 2017 13:00 pm UTC| Business
NEW YORK, March 06, 2017 -- Xcel Brands, Inc. (NASDAQ:XELB) (“Xcel” or the “Company”), a brand management and media company, today announced that it will report its fourth quarter and full year 2016 financial results...
Howard Mayer, M.D., of Shire, Joins Genocea Biosciences’ Board of Directors
Mar 06, 2017 13:00 pm UTC| Business
CAMBRIDGE, Mass., March 06, 2017 -- Genocea Biosciences, Inc. (NASDAQ:GNCA), a biopharmaceutical company developing T cell-directed vaccines and immunotherapies, today announced that Howard Mayer, M.D., senior vice...
Tetraphase Pharmaceuticals to Present at the 29th Annual ROTH Conference
Mar 06, 2017 13:00 pm UTC| Business
WATERTOWN, Mass., March 06, 2017 -- Tetraphase Pharmaceuticals, Inc. (NASDAQ:TTPH) a clinical stage biopharmaceutical company developing novel antibiotics to treat life-threatening multidrug-resistant (MDR) infections,...
Why internationalisation matters in universities
Mar 06, 2017 13:00 pm UTC| Insights & Views Business
We are living in strange times. The US has elected the most authoritarian ruler in the countrys history, while the EU has been split by the Brexit vote. Both Donald Trumps election and Brexit triggered sharp uptakes in...
Mar 06, 2017 13:00 pm UTC| Business
SOUTH SAN FRANCISCO, Calif., March 06, 2017 -- Achaogen, Inc. (NASDAQ:AKAO), a late-stage biopharmaceutical company discovering and developing novel antibacterials addressing multi-drug resistant (MDR) gram-negative...